首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1948740

疫苗管瓶監測器市場 - 全球產業規模、佔有率、趨勢、機會及按類型、應用、地區和競爭格局分類的預測（2021-2031年）

Vaccine Vial Monitor Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Multi-Dose, Single Dose), By Application (Preventive Vaccine, Therapeutics Vaccine), By Region & Competition, & Competition 2021-2031F

出版日期: 2026年01月19日 | 出版商:

TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球疫苗管瓶監測器市場預計將從 2025 年的 2.4116 億美元成長到 2031 年的 3.9149 億美元，複合年成長率為 8.41%。

這些監測器作為疫苗管瓶上的感溫變色標籤，能夠以不可逆的視覺方式顯示疫苗的累積受熱情況，並在疫苗超過其穩定性極限時發出訊號。該行業的主要驅動力是國際衛生組織強制執行的嚴格低溫運輸合規標準，以及在分發過程中減少疫苗浪費的迫切營運需求。這些根本促進因素，而非技術趨勢，源自於確保在儲存基礎設施不可靠和氣候條件極端惡劣的地區疫苗有效性和安全性的內在要求。

市場概覽
預測期	2027-2031
市場規模：2025年	2.4116億美元
市場規模：2031年	3.9149億美元
複合年成長率：2026-2031年	8.41%
成長最快的細分市場	多劑量
最大的市場	北美洲

市場擴張的一大障礙在於生產能夠在各種環境下穩定運作的化學指示劑成本高且技術複雜。近期一些機構的統計數據清楚地顯示了這些監測設備所需的物流規模。例如，全球疫苗免疫聯盟（Gavi）在2024年發布的報告顯示，其支持的低收入國家在2023年將有6900萬兒童參與常規免疫接種活動，這凸顯了對溫度敏感的產品數量龐大，需要有效的監測解決方案來維護供應鏈的完整性。

市場促進因素

全球免疫和疫苗舉措的擴展是疫苗管瓶監測器市場的主要驅動力，直接增加了大規模宣傳活動活動所需的監測器數量。隨著國際衛生組織加強在偏遠地區防治可預防疾病，對單一管瓶進行溫度檢驗以確保運輸安全的需求日益成長。大規模干預措施充分體現了這項需求的激增。例如，全球疫苗免疫聯盟（Gavi）於2024年11月宣布，將支持一項針對24個國家多達1億名兒童的免疫接種追蹤宣傳活動，其中包括麻疹疫苗。這項活動將需要數百萬個帶有疫苗瓶監測器標籤的疫苗瓶，以確保疫苗在接種時的有效性。

同時，嚴格的低溫運輸監管標準的引入正在重塑市場需求，強制要求在基礎設施建設的同時進行嚴格的溫度監控。加強開發中地區的低溫運輸是先進監控工具可靠運作的先決條件，這些工具需要在改進的系統中運行，並最大限度地減少浪費。根據聯合國兒童基金會於2024年4月發布的《2023年度供應報告》，該組織與非洲疾病管制與預防中心合作，已向30多個國家提供了價值2,500萬美元的低溫運輸設備。這些投資凸顯了對品質保證的重視，鑑於疫苗覆蓋率缺口不斷擴大，這一點至關重要。 2024年7月，世界衛生組織指出，到2023年，完全未接種任何疫苗的兒童人數（「零劑量」）將達到1450萬，凸顯了可靠的疫苗供應機制存在巨大的未滿足需求。

市場挑戰

生產穩定的化學指示劑成本高且技術複雜，是限制全球疫苗管瓶監測市場成長的主要阻礙因素。製造能夠精確響應累積熱暴露的感溫變色標籤需要複雜的化學工程技術，這必然會推高生產成本，並增加新製造商的進入門檻。這些高昂的營運成本會轉化為更高的單位成本，使得在預算嚴格控制的開發中地區，成本敏感型採購專案難以採用這項技術。因此，這些監測器的高成本迫使相關人員限制其使用或探索其他品管方法，從而降低了整體市場滲透率。

隨著醫藥物流領域的擴張，成本障礙日益凸顯。隨著分銷網路的擴張，為數百萬新增產品單元應用昂貴的監控解決方案所帶來的累積財務負擔，對供應鏈決策者而言是一個重大阻礙。國際航空運輸協會（IATA）的數據顯示，2024年4月全球航空貨運需求年增11.1%，顯示需要溫控的貨物量增加。物流吞吐量的激增進一步加劇了製造成本上漲的影響。監控日益增多的產品單元所需的投資，阻礙了這些關鍵指標的廣泛應用。

市場趨勢

隨著物聯網智慧疫苗管瓶監測器的推出，市場正在發生變革，監測功能從簡單的顏色變化視覺監測發展到即時數據記錄。這些數位指示器將關鍵的穩定性數據傳輸到雲端平台，使相關人員能夠在劣化之前進行干預，並詳細了解整個低溫運輸的運輸狀態。這項技術飛躍超越了傳統的化學標籤，能夠精確追蹤個體疫苗的完整性。對這種自動化監測的需求正在成長。根據斑馬技術公司於2024年5月發布的《醫院願景調查》，84%的非臨床醫院管理人員優先考慮為床邊給藥的藥品整合自動化數位化庫存追蹤系統。

同時，監測技術的應用範圍正從免疫接種計畫擴展到疫苗以外的其他對溫度敏感的藥品領域。隨著業界推動複雜生物製藥和基因療法的研發，對嚴格溫度檢驗的需求也擴展到更廣泛的高價值資產類別，以保護易受影響的治療藥物以及疫苗。這種多元化需求正在推動對能夠保護昂貴特藥的多功能指標的需求。這項轉變的規模令人矚目：根據醫療保健分銷聯盟 (HDA) 研究基金會 2024 年 3 月發布的報告《美國藥品低溫運輸的未來》，從 2018 年到 2024 年，對溫度敏感的產品的成長率比低溫運輸療法高出 21%。

The Global Vaccine Vial Monitor Market is projected to expand from USD 241.16 Million in 2025 to USD 391.49 Million by 2031, registering a CAGR of 8.41%. These monitors function as thermochromic labels on vaccine vials, offering an irreversible visual indication of cumulative heat exposure to signal when a vaccine has surpassed its stability limit. The industry is primarily underpinned by strict cold chain compliance standards enforced by international health bodies and the critical operational need to reduce vaccine wastage during distribution. These fundamental drivers are distinct from technological trends, stemming instead from the essential requirement to guarantee vaccine potency and safety in regions plagued by unreliable storage infrastructure or extreme climatic conditions.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 241.16 Million
Market Size 2031	USD 391.49 Million
CAGR 2026-2031	8.41%
Fastest Growing Segment	Multi-Dose
Largest Market	North America

A major obstacle to broader market expansion is the significant cost and technical complexity involved in producing stable chemical indicators that perform consistently across diverse environments. The logistical magnitude required for these monitors is highlighted by recent organizational statistics. For instance, Gavi, the Vaccine Alliance, reported in 2024 that routine immunization efforts in supported lower-income countries reached 69 million children in 2023, underscoring the substantial volume of temperature-sensitive units that require effective monitoring solutions to maintain supply chain integrity.

Market Driver

The expansion of global immunization and vaccination initiatives serves as a primary catalyst for the Vaccine Vial Monitor market, directly elevating the volume of units needed for mass campaigns. As international health bodies intensify efforts to address preventable diseases in remote areas, the logistical demand for temperature verification on individual vials increases to ensure safety during transport. This surge is illustrated by large-scale interventions; for example, Gavi, the Vaccine Alliance, announced in November 2024 its support for preventive catch-up campaigns aiming to reach up to 100 million children with measles-containing vaccines across 24 countries, a mobilization that requires millions of VVM-tagged units to guarantee potency at the point of delivery.

Concurrently, the implementation of stringent cold chain regulatory standards is reshaping market requirements by mandating rigorous temperature oversight alongside infrastructure upgrades. Strengthening the cold chain in developing regions establishes a prerequisite for advanced monitoring tools that can function reliably within improved systems to minimize spoilage. According to the UNICEF Supply Annual Report 2023, published in April 2024, the agency delivered $25 million in cold chain equipment to over 30 countries through its partnership with the Africa Centres for Disease Control and Prevention. These investments highlight a focus on quality assurance, which is critical given broader coverage gaps; the World Health Organization noted in July 2024 that the number of 'zero-dose' children receiving no vaccines hit 14.5 million in 2023, highlighting the immense unmet need for reliable vaccine delivery mechanisms.

Market Challenge

The substantial cost and technical complexity associated with manufacturing stable chemical indicators act as a primary constraint on the growth of the Global Vaccine Vial Monitor Market. Producing thermochromic labels that respond precisely to cumulative heat exposure requires advanced chemical engineering, which inherently raises production expenses and creates high barriers to entry for new manufacturers. These elevated operational costs result in higher per-unit prices, making the technology less accessible for cost-sensitive procurement programs in developing regions where budgets are strictly scrutinized. Consequently, the high expense of these monitors often compels stakeholders to limit their usage or pursue alternative quality control methods, thereby reducing overall market penetration.

This cost barrier becomes increasingly restrictive as the volume of pharmaceutical logistics expands globally. As distribution networks scale up, the cumulative financial burden of applying expensive monitoring solutions to millions of additional units becomes a significant deterrent for supply chain decision-makers. According to the International Air Transport Association (IATA), global air cargo demand increased by 11.1% in April 2024 compared to the previous year, signaling a rising volume of freight that requires temperature-controlled handling. This surge in logistical throughput amplifies the impact of high manufacturing costs, as the investment required to monitor this growing number of units stifles the broader adoption of these essential indicators.

Market Trends

The market is evolving with the adoption of IoT-enabled smart vaccine vial monitors, shifting from simple visual color changes to real-time data logging capabilities. These digital indicators transmit critical stability data to cloud platforms, enabling stakeholders to intervene before spoilage occurs and providing granular visibility into the condition of shipments throughout the cold chain. This technological leap improves upon traditional chemical labels by allowing for precise tracking of unit-level integrity. The demand for such automated oversight is rising; according to Zebra Technologies' 'Hospital Vision Study' from May 2024, 84% of non-clinical hospital leaders now prioritize the integration of automated and digitized inventory tracking systems for items administered at patients' bedsides.

Simultaneously, the expansion into non-vaccine temperature-sensitive pharmaceuticals is widening the application scope of monitoring technologies beyond immunization programs. As the industry advances complex biologics and gene therapies, the requirement for rigorous temperature verification extends to a broader category of high-value assets, protecting treatments that are as fragile as vaccines. This diversification drives demand for versatile indicators capable of protecting expensive specialty medicines. The scale of this shift is significant; according to the Healthcare Distribution Alliance (HDA) Research Foundation's report 'The Future of the U.S. Pharmaceutical Cold Chain' from March 2024, the growth of temperature-sensitive products outpaced non-cold chain therapies by 21% between 2018 and 2024.

Key Market Players

Cardinal Health Inc
Catalent Inc
Corning Incorporated
DWK Life Sciences GmbH
Elitech Technology, Inc.
Elpro-Buchs AG
EVIGENCE SENSORS Inc
Gerresheimer AG
Schott AG
Thermo Fisher Scientific Inc

Report Scope

In this report, the Global Vaccine Vial Monitor Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vaccine Vial Monitor Market, By Type

Multi-Dose
Single Dose

Vaccine Vial Monitor Market, By Application

Preventive Vaccine
Therapeutics Vaccine

Vaccine Vial Monitor Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vaccine Vial Monitor Market.

Available Customizations:

Global Vaccine Vial Monitor Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vaccine Vial Monitor Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Multi-Dose, Single Dose)
- 5.2.2. By Application (Preventive Vaccine, Therapeutics Vaccine)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Vaccine Vial Monitor Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Vaccine Vial Monitor Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Application
- 6.3.2. Canada Vaccine Vial Monitor Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Application
- 6.3.3. Mexico Vaccine Vial Monitor Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Application

7. Europe Vaccine Vial Monitor Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Vaccine Vial Monitor Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
- 7.3.2. France Vaccine Vial Monitor Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
- 7.3.3. United Kingdom Vaccine Vial Monitor Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Vaccine Vial Monitor Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Vaccine Vial Monitor Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Application

8. Asia Pacific Vaccine Vial Monitor Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Vaccine Vial Monitor Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
- 8.3.2. India Vaccine Vial Monitor Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
- 8.3.3. Japan Vaccine Vial Monitor Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application
- 8.3.4. South Korea Vaccine Vial Monitor Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Application
- 8.3.5. Australia Vaccine Vial Monitor Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Application

9. Middle East & Africa Vaccine Vial Monitor Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Vaccine Vial Monitor Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
- 9.3.2. UAE Vaccine Vial Monitor Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
- 9.3.3. South Africa Vaccine Vial Monitor Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application

10. South America Vaccine Vial Monitor Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Vaccine Vial Monitor Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
- 10.3.2. Colombia Vaccine Vial Monitor Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
- 10.3.3. Argentina Vaccine Vial Monitor Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Vaccine Vial Monitor Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Cardinal Health Inc
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Catalent Inc
15.3. Corning Incorporated
15.4. DWK Life Sciences GmbH
15.5. Elitech Technology, Inc.
15.6. Elpro-Buchs AG
15.7. EVIGENCE SENSORS Inc
15.8. Gerresheimer AG
15.9. Schott AG
15.10. Thermo Fisher Scientific Inc